Safety, tolerability, and immunogenicity of an adult pneumococcal conjugate vaccine, V116 (STRIDE-3): a randomised, double-blind, active comparator controlled, international phase 3 trialHeather Platt, Christopher Galloway, Christopher Bruno et al.|The Lancet Infectious Diseases|2024Cited by 59
Evaluating the Test-Negative Design for COVID-19 Vaccine Effectiveness Using Randomized Trial DataLeah Andrews, María L. Alcaide, Jessica Andriesen et al.|JAMA Network Open|2025Cited by 6